Selective estrogen receptor modulators (SERMs) are a new class of drugs tha
t provide a new option for addressing the health challenges of postmenopaus
al women. This review discusses the proposed mechanism of action of SERMs a
nd describes clinical findings on raloxifene, a SERM now available for trea
ting and preventing osteoporosis.